A UCLA research team tested whether ChatGPT and Gemini could correctly identify basal cell carcinoma from histologic images, ...
Krystal Biotech Inc. KRYS on Thursday released a clinical update for its intratumoral immunotherapy, KB113. The treatment ...
A new review finds that basosquamous carcinoma is molecularly closer to basal cell carcinoma but behaves aggressively enough ...
Cosibelimab (Unloxcyt; Sun Pharma), a PD-L1 inhibitor, is also approved for locally advanced and metastatic cutaneous ...
Basal cell skin cancer, the most common type, can easily be mistaken for a harmless pimple due to its appearance as a ...
Over 80% of assessed basal cell carcinoma lesions regressed across three Gorlin syndrome patients treated with KB113Substantial regression was ...
Ameluz photodynamic therapy is the first light-based treatment the FDA has approved for a skin cancer. Here's who it's for, ...
Don’t be grossed out. Of course, that’s the natural reaction to seeing these super close-up photos of skin lesions, but ...
A clinical clearance rate of 73% was noted among patients with basal cell carcinoma receiving 200 ug of doxorubicin microneedle array. A high clinical clearance rate was observed with doxorubicin ...
DelveInsight's 'Basal Cell Neoplasms Pipeline Insight 2025' report provides comprehensive global coverage of pipeline therapies for basal cell neoplasms across various stages of clinical development.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results